Common types of "weight loss peptides"

Common types of "weight loss peptides" 

The "weight loss peptides" mentioned in the market usually refer to drugs containing specific peptide components (such as GLP-1 receptor agonists), which assist in weight management by regulating appetite, delaying gastric emptying, or affecting metabolism, but must be strictly used in accordance with medical regulations. 

GLP-1 receptor agonists (such as liraglutide, semaglutide) 

This kind of medicine was originally used to treat type 2 diabetes, but it can reduce hunger and increase satiety. Now it is partially approved for obesity treatment. It needs to be administered subcutaneously and evaluated by a doctor for cardiovascular and pancreatic function risks before use. 

Synthetic peptide products 

Some peptide components that have not been clinically validated may be promoted through online channels, claiming to have "lipolytic" or "metabolic regulatory" functions, but their safety and efficacy are questionable, and there may be a risk of illegal addition.